A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy
Clinical trial NCT04072380 · COMPLETED
Trial details
- NCT number
- NCT04072380
- Sponsor
- Suven Life Sciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-21
- Primary completion
- 2023-06-07
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.